Advocacy Activities
Critical Conversations: Navigating Drug Shortages and Empowering Oncology Pharmacists
On Wednesday, June 14, HOPA, ACCC, and AVAHO will host a roundtable discussion about oncology drug shortages, with a particular focus on the management of cisplatin and carboplatin shortages. Learn more.
Virtual Hill Day 2023
Check back later this year for more details on how you can get ready for HOPA's 2024 Virtual Hill Day!
Legislative Action Center
Take action on HOPA's public policy priorities by sending a message to your member of congress.
Coalitions & Correspondence
The HOPA Public Policy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
Coalitions help Amplify Advocacy Efforts
Many times, the best way to make an impact with a broad audience is to partner with a coalition that can help advance our priority issues.
As a standing member of several national coalitions, HOPA participates in dozens of group advocacy and policy meetings each year. Often, the result is a joint letter to encourage elected officials to improve the cost, delivery, and accessibility of cancer treatment – or, to simply thank those who already have.
Partnering with coalitions:
- Builds relationships among colleagues in both cancer and pharmacy communities.
- Enables HOPA to be a prominent participant in policy discussions.
- Augments patient advocacy efforts.
HOPA supports the work of the following coalition partners in their important initiatives:
Cancer Leadership Council
A patient-centered forum of national advocacy organizations addressing public policy issues in cancer
Commission on Cancer
A patient-centered forum of national advocacy organizations addressing public policy issues in cancer
Health Professions and Nursing Education Coalition
The Health Professions and Nursing Education Coalition (HPNEC) is an alliance of over 90 organizations representing a variety of schools, programs, health professionals, and students dedicated to training a health care workforce that meets the needs of all patients.
One Voice Against Cancer
OVAC is united behind a message of long-term, sustained funding increases for cancer research and prevention on the federal level, especially for the National Institutes of Health, the National Cancer Institute and the Division of Cancer Control & Prevention at the CDC.
Patient Equal Access Coalition
Modernizing Insurance Coverage to Keep Pace with Medical Innovation.
Correspondence
In 2021-2022 alone, HOPA signed on to more than 40 joint letters to encourage elected officials to improve the cost, delivery, and accessibility of cancer treatments – or to simply thank those who already have.
All told, we signed on to 42 letters in 2021-2022, including “Cancer Moon Shoot” and the “COVID-19 and Cancer Call to Action,” which are examples of our collaboration with other organizations on topics of common concern.
- HOPA and Other National Pharmacy Organizations Submit Letter to the Biden Transition Team - November 9, 2020
- HOPA Urges Congress to Protect Funding for Cancer Research and Prevention Programs - November 24, 2020
- HOPA Thanks Senators Richard Burr and Ben Cardin for Introducing the Clinical Treatment Act (S. 4742) - October 9, 2020
- HOPA Joins in Cancer Leadership Council's Comments on the 2021 Medicare Physician Fee Schedule (CMS-1734-P) - October 5, 2020
- HOPA Joins in the Pharmacy Health Information Technology Collaborative's Comments on the 2021 Medicare Physician Fee Schedule (CMS-1734-P) - October 5, 2020
- HOPA Joins National Pharmacy Organizations in Taking Action Against Racial Injustice - October 2020
- HOPA and Other National Pharmacy Organizations Provide Comments on NASEM's "Preliminary Framework for Equitable Allocation of COVID-19 Vaccine" - September 4, 2020